New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 ...

Washington University researchers found that raising a molecule called ApoM helps eye cells sweep away harmful cholesterol ...

With funding from the National Institutes of Health, a Johns Hopkins team led by neuroscience Professor Alex Kolodkin is ...

New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 ...

Fixing problems with cholesterol metabolism might help slow or prevent a common cause of age-related vision loss, a new WashU ...

Findings could help explain the links between macular degeneration and cardiovascular disease, which both worsen with age.

A new study identifies how the molecule, called ApoM, can clear harmful cholesterol deposits linked to macular degeneration ...

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression ...

New findings reveal RG6501 cell therapy shows promising long-term visual improvements for geographic atrophy patients ...

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression ...

A new study reveals that increasing levels of apolipoprotein M (ApoM) may slow or prevent the progression of age-related macular degeneration (AMD), a major cause of blindness in older adults.